XML 15 R4.htm IDEA: XBRL DOCUMENT v3.19.1
CONDENSED CONSOLIDATED STATEMENTS OF INCOME - USD ($)
 3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Revenue    
Total revenue $ 95,757,171 $ 123,923,246
Operating expenses    
Cost of services 83,432,474 84,614,686
General and administrative expenses 10,263,960 11,301,237
Depreciation and amortization 4,417,581 5,058,512
Provision for doubtful accounts 951,014 247,102
Total expenses 99,065,029 101,221,537
(Loss) income from operations (3,307,858) 22,701,709
Other income (expense)    
Loss from equity method investments (849,657) (28,024)
Interest expense (210,979) (85,001)
Interest income 323,008 269,818
Other income 187,116 87,993
Total other (expense) income, net (550,512) 244,786
(Loss) income before (benefit from) provision for income taxes (3,858,370) 22,946,495
(Benefit from) provision for income taxes (1,408,241) 7,228,840
Net (loss) income (2,450,129) 15,717,655
Net (loss) income attributable to noncontrolling interest (2,589,793) 13,557,200
Net income attributable to Apollo Medical Holdings, Inc. $ 139,664 $ 2,160,455
Earnings per share – basic $ 0.00 $ 0.07
Earnings per share – diluted $ 0.00 $ 0.06
Weighted average shares of common stock outstanding – basic 34,496,622 32,421,467
Weighted average shares of common stock outstanding – diluted 38,074,174 38,098,373
Capitation, net [Member]    
Revenue    
Total revenue $ 71,516,778 $ 85,905,284
Health Care, Other [Member]    
Revenue    
Total revenue 10,093,841 17,986,736
Management Service [Member]    
Revenue    
Total revenue 8,996,600 12,074,572
Health Care, Patient Service [Member]    
Revenue    
Total revenue 4,080,674 6,236,628
Product and Service, Other [Member]    
Revenue    
Total revenue $ 1,069,278 $ 1,720,026